Cefaleasib

Cano Vargas-Machuca EF, Garrido-Robres JA, Marsal-Alonso C. Actualización en Cefalea para Atención Primaria. Madrid: Aula Médica; 2007.

Evans RW, Mathew NT. Handbook of Headache, 2nd Edition. Philadelphia: Lippincot, Williams & Wilkins; 2005.

Ezpeleta D. 101 cuestiones singulares sobre migraña y otras cefaleas. Barcelona: EsmonPharma; 2004.

Gómez Aranda F, Jiménez Hernández MD, eds. Diagnóstico y Tratamiento de la Cefalea. Madrid: Ergon; 2005.

Grupo de Estudio de Cefaleas de la Sociedad Española de Neurología. Actitud Diagnóstica y Terapéutica en la Cefalea. Recomendaciones 2006. Madrid: Ergon; 2006.

Láinez Andrés JM, Mateos Marcos V, eds. Cefalea: 25 situaciones concretas, 25 recomendaciones expertas. Barcelona: Euromedice; 2008.

Leira R, Pascual J (eds.). Puesta al dia en cefaleas. Neurología. 2002; 17 (Suppl 2): 1-84.

Liaño Martínez H, ed. Plan de Formación en Neurología: Dolor de Cabeza. Madrid: Ergon; 2000.

Mateos V, Pareja JA, Pascual J, eds. Tratado de Cefaleas. Madrid: Luzán 5; 2009.

Mateos Marcos V, ed. Comité ad hoc del Grupo de Estudio de la Cefalea de la Sociedad Española de Neurología (GECSEN). Guías oficiales de la Sociedad Española de Neurología. Guía para el diagnóstico y tratamiento de las cefaleas. Barcelona: Prous Science; 2006.

Mateos Marcos V, Lantéri Minet M, eds. Grupo de Estudio de Cefaleas de la Sociedad Española de Neurología (GECSEN) & Société Française dŽEtudes des Migraines et Céphalées (SFEMC). Actualización en Cefaleas. Madrid: Egraf; 2006.

Mateos Marcos V, Díaz Insa S, eds. Cefaleas: 25 casos representativos, 25 aproximaciones expertas. Barcelona: Euromedice; 2009.

Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KM, eds. The Headaches, 3rd Edition. Philadelphia: Lippincot, Williams & Wilkins; 2006.

Pozo Rosich P, Oterino Durán A, Sánchez del Río González M, Pascual Gómez J, Mateos Marcos V. Fronteras actuales en Cefaleas. Madrid: Egraf; 2006.

Sánchez Del Río M, Pascual Gómez J, Pozo Rosich P, Mateos Marcos V (coordinador). Cefaleas predecibles: actitudes prácticas. Madrid: Ergon; 2009.

Sánchez del Río M, Pascual Gómez J, Mederer Hengstl S, Caminero Rodríguez AB, Mateos Marcos V (coordinador). Decisiones avaladas en cefaleas. Madrid: Ergon; 2008.

Silberstein SD, Lipton RB, Dodick DW, eds. WolfŽs Headache and Other Head Pain, 8th Edition. New York: Oxford University Press; 2007.

Silberstein SD, Lipton RB, Goadsby PJ, eds. Headache in clinical practice, 2nd Edition. London: Martin Dunitz; 2002.

Titus F, Acarín N, Dexeus S, eds. Cefalea, 2ª Edición. Madrid: Harcourt; 1999.

Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004; 24 Suppl 1: 9-160.

Headache Classification Committee, Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, Göbel H, Lainez MJ, Lance JW, Lipton RB, Nappi G, Sakai F, Schoenen J, Silberstein SD, Steiner TJ. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006; 26: 742-6.

Láinez JM. La clasificación de las cefaleas de la International Headache Society. Luces y sombras. Neurología. 2004; 19: 339-43.

Silberstein SD, Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, Göbel H, Lainez MJ, Lance JW, Lipton RB, Nappi G, Sakai F, Schoenen J, Steiner TJ; International Headache Society. The International Classification of Headache Disorders, 2nd Edition (ICHD-II)--revision of criteria for 8.2 Medication-overuse headache. Cephalalgia. 2005; 25: 460-5.

Sun-Edelstein C, Bigal ME, Rapoport AM. Chronic migraine and medication overuse headache: clarifying the current International Headache Society classification criteria. Cephalalgia. 2009; 29: 445-52.

Bigal ME, Lipton RB, Stewart WF. The epidemiology and impact of migraine. Curr Neurol Neurosci Rep. 2004; 4: 98-104.

Bigal ME, Lipton RB. The epidemiology, burden, and comorbidities of migraine. Neurol Clin. 2009; 27: 321-34.

Cull RE, Wells NEJ, Miocevich ML. The economic cost of migraine. Br J Med Econom. 1992; 2: 103-5.

Jensen R, Stovner LJ. Epidemiology and comorbidity of headache. Lancet Neurol. 2008; 7: 354-61.

Láinez JM. Prevalencia de la migraña en el medio laboral y su repercusión económica. Rev Esp Med Trab. 1995; Suppl 1: S3-9.

Lipton RB, Bigal ME. Migraine: epidemiology, impact, and risk factors for progression. Headache. 2005; 45 Suppl 1: S3-13.

Lipton RB, Bigal ME. Ten lessons on the epidemiology of migraine. Headache. 2007; 47 Suppl 1: S2-9.

Osterhaus JT, Gutterman DL, Plachetka JR. Healthcare resource and lost labour costs of migraine headache in the US. Pharmacoeconomics. 1992; 2: 67-76.

Zavala HA, Sarabia BB. Epidemiología e impacto socio-económico de la migraña. Revista Neurológica Argentina. 2003; 28: 79-84.

Boonmak P, Boonmak S. Epidural blood patching for preventing and treating post-dural puncture headache. Cochrane Database Syst Rev. 2010; (1): CD001791.

Rasmussen BK, Olesen J. Symptomatic and nonsymptomatic headaches in a general population. Neurology. 1992; 42: 1225-31.

Sudlow C, Warlow C. Posture and fluids for preventing post-dural puncture headache. Cochrane Database Syst Rev. 2002; (2): CD001790.

Bigal ME, Bordini CA, Speciali JG. Intravenous metamizol (Dipyrone) in acute migraine treatment and in episodic tension-type headache--a placebo-controlled study. Cephalalgia. 2001; 21: 90-5.

Bigal ME, Bordini CA, Tepper SJ, Speciali JG. Intravenous dipyrone in the acute treatment of migraine without aura and migraine with aura: a randomized, double blind, placebo controlled study. Headache. 2002; 42: 862-71.

Bigal ME, Kurth T, Santanello N, Buse D, Golden W, Robbins M, Lipton RB. Migraine and cardiovascular disease. A population-based study. Neurology. 2010; 74: 628-35.

Connor KM, Shapiro RE, Diener HC, Lucas S, Kost J, Fan X, Fei K, Assaid C, Lines C, Ho TW. Randomized, controlled trial of telcagepant for the acute treatment of migraine. Neurology. 2009; 73: 970-7.

Dodick D, Lipton RB, Martin V, Papademetriou V, Rosamond W, MaassenVanDenBrink A, Loutfi H, Welch KM, Goadsby PJ, Hahn S, Hutchinson S, Matchar D, Silberstein S, Smith TR, Purdy RA, Saiers J; Triptan Cardiovascular Safety Expert Panel. Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine. Headache. 2004; 44: 414-25.

Dodick DW, Mauskop A, Elkind AH, DeGryse R, Brin MF, Silberstein SD; BOTOX CDH Study Group. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study. Headache. 2005; 45: 315-24.

d’Onofrio F, Bussone G, Cologno D Petretta V, Buzzi MG, Tedeschi G, Bonavita V, Cicarelli G. Restless legs syndrome and primary headaches: a clinical study. Neurol Sci. 2008; 29 Suppl 1: S169-72.

Duval C, Norton L. Tremor in patients with migraine. Headache. 2006; 46: 1005-10.

Edvinsson L. CGRP-receptor antagonism in migraine treatment. Lancet. 2008; 372: 2089-90.

Elliott D. Migraine and stroke: current perspectives. Neurol Res. 2008; 30: 801-12.

Evans RW, Taylor FR. "Natural" or alternative medications for migraine prevention. Headache. 2006; 46: 1012-8.

Evans RW, Grosberg BM. Retinal migraine: migraine associated with monocular visual symptoms. Headache. 2008; 48: 142-5.

Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, Sándor PS; European Federation of Neurological Societies. EFNS guideline on the drug treatment of migraine--revised report of an EFNS task force. Eur J Neurol. 2009; 16: 968-81.

Ferrari MD, Roon KI, Lipton RB, Goadsby PJ. Oral triptans (serotonin 5-HT_1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet. 2001; 358: 1668-75.

Goadsby PJ, Lipton RB, Ferrari MD. Migraine--current understanding and treatment. N Engl J Med. 2002; 346: 257-70.

Grosberg BM, Solomon S, Friedman DI, Lipton RB. Retinal migraine reappraised. Cephalalgia. 2006; 26: 1275-86.

Ho TW, Ferrari MD, Dodick DW, Galet V, Kost J, Fan X, Leibensperger H, Froman S, Assaid C, Lines C, Koppen H, Winner PK. Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial. Lancet. 2008; 372: 2115-23.

Láinez M. Clinical benefits of early triptan therapy for migraine. Cephalalgia. 2004; 24 Suppl 2: S24-30.

Láinez MJ, Domínguez M, Rejas J, Palacios G, Arriaza E, García-García M, Madrigal M. Development and validation of Migraine Screen Questionaire (MS-Q). Headache. 2005; 45: 1328-38.

Mathew NT, Frishberg BM, Gawel M, Dimitrova R, Gibson J, Turkel C; BOTOX CDH Study Group. Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Headache. 2005; 45: 293-307.

Moja PL, Cusi C, Sterzi RR, Canepari C. Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches. Cochrane Database Syst Rev. 2005; (3): CD002919.

Mulleners WM, Chronicle EP. Anticonvulsants in migraine prophylaxis: a Cochrane review. Cephalalgia. 2008; 28: 585-97.

Pascual J, Caminero AB, Mateos V, Roig C, Leira R, García-Moncó C, Laínez MJ. Preventing disturbing migraine aura with lamotrigine: an open study. Headache. 2004; 44: 1024-8.

Pascual J, Mateos V, Roig C, Sanchez-Del-Rio M, Jiménez D. Marketed oral triptans in the acute treatment of migraine: a systematic review on efficacy and tolerability. Headache. 2007; 47: 1152-68.

Pascual-Gómez J. Papel de los neuromoduladores en el tratamiento preventivo de la migraña. Rev Neurol. 2009; 49: 25-32

Pascual-Gómez J. Migraña y gestación: una relación compleja. Rev Neurol. 2010; 50: 321-4.

Pittler MH, Ernst E. Feverfew for preventing migraine. Cochrane Database Syst Rev. 2004; (1): CD002286.

Ramacciotti AS, Soares BG, Atallah AN. Dipyrone for acute primary headaches. Cochrane Database Syst Rev. 2007; (2): CD004842.

Sacco S, Olivieri L, Bastianello S, Carolei A. Comorbid neuropathologies in migraine. J Headache Pain. 2006; 7: 222-30.

Sánchez del Rio M, Alvarez Linera J. Functional neuroimaging of headaches. Lancet Neurol. 2004; 3: 645-51.

Sanchez-Del-Rio M, Reuter U, Moskowitz MA. New insights into migraine pathophysiology. Curr Opin Neurol. 2006; 19: 294-8.

Scher AI, Gudmundsson LS, Sigurdsson S, Ghambaryan A, Aspelund T, Eiriksdottir G, van Buchem MA, Gudnason V, Launer LJ. Migraine headache in middle age and late-life brain infarcts. JAMA. 2009; 301: 2563-70.

Tfelt-Hansen P, Saxena PR, Dahlöf C, Pascual J, Láinez M, Henry P, Diener H, Schoenen J, Ferrari MD, Goadsby PJ. Ergotamine in the acute treatment of migraine. A review and European consensus. Brain. 2000; 123: 9-18.

Ailani J. Chronic tension-type headache. Curr Pain Headache Rep. 2009; 13: 479-83.

Bendtsen L, Jensen R. Tension-type headache: the most common, but also the most neglected headache disorder. Curr Opin Neurol. 2006; 19: 305-9.

Bigal ME, Rapoport AM, Hargreaves R. Advances in the pharmacologic treatment of tension-type headache. Curr Pain Headache Rep. 2008; 12: 442-6.

Chen Y. Advances in the pathophysiology of tension-type headache: from stress to central sensitization. Curr Pain Headache Rep. 2009; 13: 484-94.

Crystal SC, Grosberg BM. Tension-type headache in the elderly. Curr Pain Headache Rep. 2009; 13: 474-8.

Fernández-de-las-Peñas C, Schoenen J. Chronic tension-type headache: what is new? Curr Opin Neurol. 2009; 22: 254-61.

Fernández-de-las-Peñas C, Cuadrado ML, Pareja JA. Asociación de puntos gatillo miofasciales en la cefalea tensional crónica y episódica. Fisioterapia. 2010; doi:10.1016/j.ft.2009.10.006.

Cohen AS, Matharu MS, Goadsby PJ. Trigeminal autonomic cephalalgias: current and future treatments. Headache. 2007; 47: 969-80.

Goadsby PJ, Cittadini E, Burns B, Cohen AS. Trigeminal autonomic cephalalgias: diagnostic and therapeutic developments. Curr Opin Neurol. 2008; 21: 323-30.

Leone M, Bussone G. Pathophysiology of trigeminal autonomic cephalalgias. Lancet Neurol. 2009; 8: 755-64.

May A. Cluster headache: pathogenesis, diagnosis, and management. Lancet. 2005; 366: 843-55.

Rozen TD. Trigeminal autonomic cephalalgias. Neurol Clin. 2009; 27: 537-56.

Tfelt-Hansen P. Acute pharmacotherapy of migraine, tension-type headache, and cluster headache. J Headache Pain. 2007; 8: 127-34.

Tyagi A, Matharu M. Evidence base for the medical treatments used in cluster headache. Curr Pain Headache Rep. 2009; 13: 168-78.

Bigal ME. Diagnostic evaluation and treatment of trigeminal neuralgia. Curr Pain Headache Rep. 2009; 13: 256-7.

Caminero AB, Mateos V. Aproximación clínica a las neuralgias craneales. Rev Neurol. 2009; 48: 365-73.

Gronseth G, Cruccu G, Alksne J, Argoff C, Brainin M, Burchiel K, Nurmikko T, Zakrzewska JM. Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies. Neurology. 2008; 71: 1183-90.

Andrasik F, Buse DC, Grazzi L. Behavioral medicine for migraine and medication overuse headache. Curr Pain Headache Rep. 2009; 13: 241-8.

Bigal ME, Lipton RB. The differential diagnosis of chronic daily headaches: an algorithm-based approach. J Headache Pain. 2007; 8: 263-72.

Bigal ME, Lipton RB. What predicts the change from episodic to chronic migraine? Curr Opin Neurol. 2009; 22: 269-76.

Dodick DW. Clinical practice. Chronic daily headache. NEJM. 2006; 354: 158-65.

Evers S, Marziniak M. Clinical features, pathophysiology, and treatment of medication overuse headache. Lancet Neurol. 2010; 9: 391-401.

Hagen K, Albretsen C, Vilming S, et al. Management of medication overuse headache: 1-year randomized multicentre open-label trial. Cephalalgia. 2008; 29: 221–32

Linde K, Allais G, Brinkhaus B, Manheimer E, Vickers A, White AR. Acupuncture for migraine prophylaxis. Cochrane Database Syst Rev. 2009; (1): CD001218.

Linde K, Allais G, Brinkhaus B, Manheimer E, Vickers A, White AR. Acupuncture for tension-type headache. Cochrane Database Syst Rev. 2009; (1): CD007587.

Lipton RB. Tracing transformation: chronic migraine classification, progression, and epidemiology. Neurology. 2009; 72 (Suppl 5): S3-7.

Mathew NT. Dynamic optimization of chronic migraine treatment: current and future options. Neurology. 2009; 72 (Suppl 5): S14-20.

Rapoport AM. Medication overuse headache: awareness, detection and treatment. CNS Drugs. 2008; 22: 995-1004.

Rossi P, Jensen R, Nappi G, Allena M; COMOESTAS Consortium. A narrative review on the management of

medication overuse headache: the steep road from experience to evidence. J Headache Pain. 2009; 10: 407-17.

Vargas BB, Dodick DW. The face of chronic migraine: epidemiology, demographics, and treatment strategies.